Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia

J. N. Martin, T. B. Bair, N. Bode, W. T. Dauer, P. Gonzalez-Alegre

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

DYT1, the most common inherited dystonia, is caused by a common dominant mutation in the TOR1A gene that leads to a glutamic acid deletion in the protein torsinA. Wild-type torsinA locates preferentially in the endoplasmic reticulum while the disease-linked mutant accumulates in the nuclear envelope. As a result, it has been proposed that DYT1 pathogenesis could result either from transcriptional dysregulation caused by abnormal interactions of mutant torsinA with nuclear envelope proteins, or from a loss of torsinA function in the endoplasmic reticulum that would impair specific neurobiological pathways. Aiming to determine whether one or both of these potential mechanisms are implicated in DYT1 pathogenesis, we completed unbiased transcriptional and proteomic profiling in well-characterized neural cell lines that inducibly express wild-type or mutant torsinA. These experiments demonstrated that the accumulation of mutant torsinA in the nuclear envelope is not sufficient to cause transcriptional dysregulation. However, we detected expression changes at the protein level that, together with other reports, suggest a potential implication of torsinA on energy metabolism and regulation of the redox state. Furthermore, several proteins identified in this study have been previously linked to other forms of dystonia. In conclusion, our results argue against the hypothesis of transcriptional dysregulation in DYT1 dystonia, suggesting potential alternative pathogenic pathways.

Original languageEnglish (US)
Pages (from-to)563-572
Number of pages10
JournalNeuroscience
Volume164
Issue number2
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Dystonia
Nuclear Envelope
Proteomics
Endoplasmic Reticulum
Proteins
Nuclear Proteins
Energy Metabolism
Oxidation-Reduction
Glutamic Acid
Cell Line
Mutation
Genes

Keywords

  • dystonia
  • DYT1
  • metabolism
  • microarray
  • proteomics
  • torsina

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia. / Martin, J. N.; Bair, T. B.; Bode, N.; Dauer, W. T.; Gonzalez-Alegre, P.

In: Neuroscience, Vol. 164, No. 2, 01.12.2009, p. 563-572.

Research output: Contribution to journalArticle

Martin, J. N. ; Bair, T. B. ; Bode, N. ; Dauer, W. T. ; Gonzalez-Alegre, P. / Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia. In: Neuroscience. 2009 ; Vol. 164, No. 2. pp. 563-572.
@article{ace8c7ba79df44c1980a0e5e9e0fbe6c,
title = "Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia",
abstract = "DYT1, the most common inherited dystonia, is caused by a common dominant mutation in the TOR1A gene that leads to a glutamic acid deletion in the protein torsinA. Wild-type torsinA locates preferentially in the endoplasmic reticulum while the disease-linked mutant accumulates in the nuclear envelope. As a result, it has been proposed that DYT1 pathogenesis could result either from transcriptional dysregulation caused by abnormal interactions of mutant torsinA with nuclear envelope proteins, or from a loss of torsinA function in the endoplasmic reticulum that would impair specific neurobiological pathways. Aiming to determine whether one or both of these potential mechanisms are implicated in DYT1 pathogenesis, we completed unbiased transcriptional and proteomic profiling in well-characterized neural cell lines that inducibly express wild-type or mutant torsinA. These experiments demonstrated that the accumulation of mutant torsinA in the nuclear envelope is not sufficient to cause transcriptional dysregulation. However, we detected expression changes at the protein level that, together with other reports, suggest a potential implication of torsinA on energy metabolism and regulation of the redox state. Furthermore, several proteins identified in this study have been previously linked to other forms of dystonia. In conclusion, our results argue against the hypothesis of transcriptional dysregulation in DYT1 dystonia, suggesting potential alternative pathogenic pathways.",
keywords = "dystonia, DYT1, metabolism, microarray, proteomics, torsina",
author = "Martin, {J. N.} and Bair, {T. B.} and N. Bode and Dauer, {W. T.} and P. Gonzalez-Alegre",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.neuroscience.2009.07.068",
language = "English (US)",
volume = "164",
pages = "563--572",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia

AU - Martin, J. N.

AU - Bair, T. B.

AU - Bode, N.

AU - Dauer, W. T.

AU - Gonzalez-Alegre, P.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - DYT1, the most common inherited dystonia, is caused by a common dominant mutation in the TOR1A gene that leads to a glutamic acid deletion in the protein torsinA. Wild-type torsinA locates preferentially in the endoplasmic reticulum while the disease-linked mutant accumulates in the nuclear envelope. As a result, it has been proposed that DYT1 pathogenesis could result either from transcriptional dysregulation caused by abnormal interactions of mutant torsinA with nuclear envelope proteins, or from a loss of torsinA function in the endoplasmic reticulum that would impair specific neurobiological pathways. Aiming to determine whether one or both of these potential mechanisms are implicated in DYT1 pathogenesis, we completed unbiased transcriptional and proteomic profiling in well-characterized neural cell lines that inducibly express wild-type or mutant torsinA. These experiments demonstrated that the accumulation of mutant torsinA in the nuclear envelope is not sufficient to cause transcriptional dysregulation. However, we detected expression changes at the protein level that, together with other reports, suggest a potential implication of torsinA on energy metabolism and regulation of the redox state. Furthermore, several proteins identified in this study have been previously linked to other forms of dystonia. In conclusion, our results argue against the hypothesis of transcriptional dysregulation in DYT1 dystonia, suggesting potential alternative pathogenic pathways.

AB - DYT1, the most common inherited dystonia, is caused by a common dominant mutation in the TOR1A gene that leads to a glutamic acid deletion in the protein torsinA. Wild-type torsinA locates preferentially in the endoplasmic reticulum while the disease-linked mutant accumulates in the nuclear envelope. As a result, it has been proposed that DYT1 pathogenesis could result either from transcriptional dysregulation caused by abnormal interactions of mutant torsinA with nuclear envelope proteins, or from a loss of torsinA function in the endoplasmic reticulum that would impair specific neurobiological pathways. Aiming to determine whether one or both of these potential mechanisms are implicated in DYT1 pathogenesis, we completed unbiased transcriptional and proteomic profiling in well-characterized neural cell lines that inducibly express wild-type or mutant torsinA. These experiments demonstrated that the accumulation of mutant torsinA in the nuclear envelope is not sufficient to cause transcriptional dysregulation. However, we detected expression changes at the protein level that, together with other reports, suggest a potential implication of torsinA on energy metabolism and regulation of the redox state. Furthermore, several proteins identified in this study have been previously linked to other forms of dystonia. In conclusion, our results argue against the hypothesis of transcriptional dysregulation in DYT1 dystonia, suggesting potential alternative pathogenic pathways.

KW - dystonia

KW - DYT1

KW - metabolism

KW - microarray

KW - proteomics

KW - torsina

UR - http://www.scopus.com/inward/record.url?scp=70349746735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349746735&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2009.07.068

DO - 10.1016/j.neuroscience.2009.07.068

M3 - Article

C2 - 19665049

AN - SCOPUS:70349746735

VL - 164

SP - 563

EP - 572

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -